Keith Katkin
Chairman bei ELEDON PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Dennis Podlesak | M | 66 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | 20 Jahre |
| Christine Ocampo | F | 51 |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 16 Jahre |
| Bryan E. Smith | M | 45 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 Jahre |
| James Robinson | M | 54 | 5 Jahre | |
| Pierre Legault | M | 63 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 7 Jahre |
| Sef P. Kurstjens | M | 60 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 Jahre |
| Michael Metzger | M | 53 | 9 Jahre | |
| Briggs Morrison | M | 65 | 9 Jahre | |
| Keith Goldan | M | 52 | 2 Jahre | |
| Steven N. Perrin | M | 59 | 4 Jahre | |
| Shigeyuki Nishinaka | M | 59 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 5 Jahre |
| Myrtle Potter | F | 65 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 Jahre |
| Eckard Weber | M | 73 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Marvin White | M | 61 |
Indiana University
| 7 Jahre |
| Gregg Lapointe | M | 65 | 7 Jahre | |
| Zsolt Pál Harsányi | M | 80 | 20 Jahre | |
| Donald DeGolyer | M | 63 | 1 Jahre | |
| David-Alexandre C. Gros | M | 51 | 4 Jahre | |
| Jennifer Fox | F | 51 | 6 Jahre | |
| Kathryn Zoon | M | 75 | 8 Jahre | |
| Alison Hannah | M | 63 | 3 Jahre | |
| Jennifer Jarrett | F | 53 | 6 Jahre | |
| Catherine Madigan | M | 52 | - | |
| June Lee | M | 58 | 4 Jahre | |
| Brian Kotzin | M | 74 | 7 Jahre | |
| Jan Hillson | M | 71 | 3 Jahre | |
| Nori Ebersole | F | 60 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 7 Jahre |
| Paul Little | M | 60 | 3 Jahre | |
| Kelly Parker | M | - | 9 Jahre | |
| Richard Lindahl | M | 70 | 6 Jahre | |
| Sujata Dayal | F | 61 | 2 Jahre | |
| Jane Wasman | F | 67 | 5 Jahre | |
| Louis Sullivan | M | 90 | 19 Jahre | |
| Walter C. Ogier | M | 67 | 4 Jahre | |
| Ronald Richard | M | 68 | 19 Jahre | |
| Joseph Papa | M | 68 | - | |
| Allan Kirk | M | - | 1 Jahre | |
| Neil Gallagher | M | 60 | 1 Jahre | |
| Luke Albrecht | M | 45 | 8 Jahre | |
| Sharon P. Klahre | F | - | 2 Jahre | |
| William Meury | M | 56 | 6 Jahre | |
| Neal Fowler | M | 62 | 1 Jahre | |
| John S. McBride | M | 72 | 7 Jahre | |
| Peter Ordentlich | M | 55 | 19 Jahre | |
| Kamil Ali-Jackson | F | 65 | 3 Jahre | |
| Martin Huber | M | 64 | 3 Jahre | |
| David Hovland | M | - | 6 Jahre | |
| Stephanie Duatschek | F | - | - | |
| John Herberger | M | - | 2 Jahre | |
| Coleen Glessner | F | 53 | 4 Jahre | |
| Aubrey Watkins | M | - | - | |
| Julie Patel | F | - | 2 Jahre | |
| David Santos | M | 61 | 4 Jahre | |
| Aneta Ferguson | F | - | 9 Jahre | |
| Jack A. Bowling | M | - |
Brain Injury Association of America, Inc.
| - |
| Kevin McManus | M | - | 1 Jahre | |
| Cornelia Haag-Molkenteller | M | 66 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 6 Jahre |
| Christopher W. Frech | M | - | 15 Jahre | |
| Esteban S. Masuda | M | - | 8 Jahre | |
| Laura Kennedy | F | - | 8 Jahre | |
| Sharon Solomon | F | - | 7 Jahre | |
| Heather N. Vinas | F | 44 |
Brain Injury Association of America, Inc.
| - |
| Bill Harrington | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Daniel Hetu | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| John Pacifico | M | - |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Brent Ahrens | M | 61 |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | - |
| Eliezer Katz | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Kramer | M | 66 | 24 Jahre | |
| Jon S. Kuwahara | M | 59 | 7 Jahre | |
| Richard Shea | M | 72 | 6 Jahre | |
| Fuad El Hibri | M | 66 | 24 Jahre | |
| Rohan Palekar | M | 58 | 5 Jahre | |
| Michael McFadden | M | 57 |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | 9 Jahre |
| Erez Chimovits | M | 60 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | 3 Jahre |
| Gregory P. Hanson | M | 77 | 8 Jahre | |
| Jodie Morrison | F | 48 | 5 Jahre | |
| Gregory Flesher | M | 54 | 13 Jahre | |
| Catherine Turkel | M | 63 |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | 5 Jahre |
| Michael Cruse | M | 52 | 14 Jahre | |
| Atul Saran | M | 50 | 6 Jahre | |
| Alexander Nolte | M | 52 | 6 Jahre | |
| Eric Brandt | M | 62 | 2 Jahre | |
| Donald G. Payan | M | 75 | 20 Jahre | |
| Kim Kamdar | M | 56 | 11 Jahre | |
| Terry Stapp | M | - |
Indiana University
| 8 Jahre |
| Keith M. McGahan | M | - | 1 Jahre | |
| Stephen Sherwin | M | 75 | 17 Jahre | |
| Luke Evnin | M | 60 | 6 Jahre | |
| Cheryl L. Cohen | F | 58 | 5 Jahre | |
| Henry Chen | M | 53 | 3 Jahre | |
| Bong-Joo Lee | M | 64 |
Indiana University
| 6 Jahre |
| George Joulwan | M | 84 | 10 Jahre | |
| Michael Curless | M | 60 |
Indiana University
| 7 Jahre |
| Steven Basta | M | 59 |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | 7 Jahre |
| Bob Miller | M | - |
Indiana University
| 8 Jahre |
| Katherine Strei | F | 62 | 7 Jahre | |
| Bruce E. Beerbower | M | - |
Indiana University
| 5 Jahre |
| Anand Deshpande | M | 62 |
Indiana University
| 4 Jahre |
| John T. Hackett | M | 89 |
Indiana University
| 3 Jahre |
| David Saul | M | - |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
| Bermuda | 9 | 9,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Keith Katkin
- Persönliches Netzwerk
